Pacira Pharmaceuticals Return on Equity:-80.11% for Dec. 31, 2012
Pacira Pharmaceuticals Return on Equity Chart
Pacira Pharmaceuticals Historical Return on Equity DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|Dec. 31, 2012||-80.11%|
|Sept. 30, 2012||-93.35%|
|June 30, 2012||-103.7%|
|March 31, 2012||-148.1%|
|Dec. 31, 2011||-319.4%|
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
PCRX Return on Equity Benchmarks
PCRX Return on Equity Rankings
4336 of 8002
410 of 684 in Healthcare
28 of 54 in Drug Manufacturers - Major
PCRX Return on Equity Range, Past 5 Years
Zacks May 10
Seeking Alpha May 8